M Uram1. 1. Manhattan Eye, Ear and Throat Hospital, New York.
Abstract
PURPOSE: The purpose of this article is to describe the function of the ophthalmic laser microendoscope as it pertains to endophotocoagulation in the management of vitreoretinal disease. METHODS: Fifty-four consecutive vitrectomies with endophotocoagulation were performed using the ophthalmic laser microendoscope instead of endoillumination and endophotocoagulation probes. Intraoperative and postoperative efficacy and complications were evaluated. RESULTS: The ophthalmic laser microendoscope was used to illuminate and view the retina and to deliver diode laser energy in the management of posterior retinal breaks, proliferative retinopathies, and proliferative vitreoretinopathy. The technique of endophotocoagulation was similar to that used routinely in vitreoretinal surgery. The photocoagulation lesions that were created were identical to those delivered by standard endophotocoagulation probes. Intraoperative complications were few, consisting of transient mild retinal or choroidal hemorrhages. Severe postoperative complications related to endophotocoagulation or to use of the ophthalmic laser microendoscope were not observed. CONCLUSION: The ophthalmic laser microendoscope appears to be a safe and effective method of delivering diode laser energy to the retina while simultaneously providing illumination, video recording, and a clear endoscopic view despite anterior segment conditions that might otherwise preclude adequate visualization and treatment. Fewer instrument insertions/removals were required for endophotocoagulation. Post-treatment search for peripheral iatrogenic retinal breaks was accomplished by endoscopy.
PURPOSE: The purpose of this article is to describe the function of the ophthalmic laser microendoscope as it pertains to endophotocoagulation in the management of vitreoretinal disease. METHODS: Fifty-four consecutive vitrectomies with endophotocoagulation were performed using the ophthalmic laser microendoscope instead of endoillumination and endophotocoagulation probes. Intraoperative and postoperative efficacy and complications were evaluated. RESULTS: The ophthalmic laser microendoscope was used to illuminate and view the retina and to deliver diode laser energy in the management of posterior retinal breaks, proliferative retinopathies, and proliferative vitreoretinopathy. The technique of endophotocoagulation was similar to that used routinely in vitreoretinal surgery. The photocoagulation lesions that were created were identical to those delivered by standard endophotocoagulation probes. Intraoperative complications were few, consisting of transient mild retinal or choroidal hemorrhages. Severe postoperative complications related to endophotocoagulation or to use of the ophthalmic laser microendoscope were not observed. CONCLUSION: The ophthalmic laser microendoscope appears to be a safe and effective method of delivering diode laser energy to the retina while simultaneously providing illumination, video recording, and a clear endoscopic view despite anterior segment conditions that might otherwise preclude adequate visualization and treatment. Fewer instrument insertions/removals were required for endophotocoagulation. Post-treatment search for peripheral iatrogenic retinal breaks was accomplished by endoscopy.